Urigan

· 3 min read
Urigan

urigan


Utilization of Urigan in Cystitis Management
Urigan incorporates an extract derived from birch leaves alongside lovage root, both of which possess diuretic and anti-inflammatory properties beneficial for urinary tract infections. The recommended dosage is 50 drops taken three times daily, diluted in water. Its mode of action revolves around promoting diuresis, which facilitates the mechanical expulsion of bacteria from the bladder.
The primary components of Urigan hinder the adhesion of Escherichia coli bacteria to the epithelial lining of the urinary tract, a phenomenon substantiated by microbiological analyses. Flavonoids and essential oils impart antibacterial effects, while saponins aid in the relaxation of smooth muscle, thus alleviating pain linked to inflammation.
Treatment with Urigan generally spans 2 to 4 weeks, contingent on the severity of the patient's symptoms. Many users observe a decrease in dysuria and urinary frequency within just 3 to 5 days of consistent intake. Additionally, this formulation can be used alongside antibiotics, which not only boosts the overall therapeutic impact but can also reduce the treatment duration by approximately 30%.
Clinical assessments involving 240 women with recurrent infections have indicated that a preventive regimen of Urigan over six months resulted in a 56% decline in inflammation episodes. The preparation is well-tolerated, with fewer than 2% of users experiencing side effects, primarily mild gastrointestinal discomfort.
Individuals with allergies to any of the ingredients, heart or kidney failure, dehydration, and swelling due to circulatory issues should avoid this product. Pregnant women are advised to seek medical consultation before using it, as safety data during this period is limited.
How Urigan Functions Against Cystitis-Inducing Bacteria
Urigan features cranberry extract, whose principal active component is proanthocyanidins type A (PAC-A) at a minimum concentration of 36 mg per capsule. These compounds obstruct the adherence of Escherichia coli bacteria to the epithelial lining of the urinary tract by altering the structure of bacterial fimbriae, thereby preventing pathogens from anchoring to host cells. This anti-adhesion mechanism specifically targets uropathogenic strains of E. coli harboring P and type 1 fimbriae, which contribute to 80-90% of lower urinary tract infections.
Proanthocyanidins modify the physicochemical characteristics of the bacterial surface, neutralizing electric charges necessary for binding to cellular receptors. Consequently, bacteria lacking the ability to adhere remain suspended in urine and are naturally flushed out during urination instead of settling in the bladder. The active components stay effective in urine for 8 to 12 hours post-consumption, ensuring ongoing protection against reinfection.
Furthermore, the preparation exhibits anti-inflammatory properties by diminishing the production of pro-inflammatory cytokines IL-6 and IL-8 in the bladder's epithelial cells. Clinical trials indicate that regular intake of cranberry extract at 72 mg of PAC-A daily can reduce the frequency of cystitis recurrences by 40-50% in women with chronic infections. Additional components of Urigan, such as vitamin C, acidify urine to a pH of 5.5-6.0, creating a hostile environment for the growth of anaerobic bacteria and uropathogenic strains of Proteus mirabilis.
Dosage Instructions and Administration of Urigan During Urinary Tract Infections
The typical dosage for Urigan in treating cystitis is 1-2 capsules, taken twice daily, preferably in the morning and evening, alongside a generous amount of water (at least 200 ml). It should be consumed either before meals or during eating to minimize potential gastrointestinal discomfort. The treatment duration typically ranges from 7 to 10 days for acute infections, extendable to 14-21 days for recurrent cases. The manufacturer advises against exceeding the daily limit of 4 capsules unless otherwise directed by a healthcare professional based on the patient's condition.
While using Urigan, patients are encouraged to augment their fluid intake to between 2-2.5 liters daily, facilitating the expulsion of bacteria from the urinary system. Regular intake at consistent intervals is crucial. If a dose is missed, patients should not double the next one but rather continue with the prescribed schedule. Should there be no alleviation of symptoms after 3-4 days of treatment, or if fever, hematuria, or increased lumbar pain arises, immediate consultation with a physician is essential. The preparation may be safely combined with antibiotics prescribed by a healthcare provider, ensuring a 2-hour interval between the two medications.